<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03893760</url>
  </required_header>
  <id_info>
    <org_study_id>NGCH001</org_study_id>
    <nct_id>NCT03893760</nct_id>
  </id_info>
  <brief_title>Assessment of Right Ventricular Function in Advanced Heart Failure</brief_title>
  <official_title>Assessment of Right Ventricular Function in Advanced Heart Failure: Feasibility and Reliability of Right Ventricular Elastance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ITAB - Institute for Advanced Biomedical Technologies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ITAB - Institute for Advanced Biomedical Technologies</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We examined the feasibility and reliability of a combined echocardiographic and right heart
      catheterization (RHC) approach for right ventriculo/arterial (R-V/A) coupling assessment in
      HF patients with dilated cardiomyopathy (D-CMP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, retrospective cross-sectional study. In 2016-17, for 6 months, we
      evaluated for eligibility 81 consecutive D-CMP patients afferent to &quot;Niguarda Great
      Metropolitan Hospital&quot; for RHC and echocardiography. All participants underwent the exams in
      the context of heart-transplant or advanced HF evaluation. Inclusion criteria were: 18 years
      old, given informed consent, D-CMP, New York Heart Association (NYHA) functional class II or
      III and reduced EF (≤ 35%). On the contrary, exclusion criteria were: missing the inclusion
      criteria and refused informed consent. The final sample consisted of 68 study participants
      (mean age 64±7 years, 82 % male).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with altered Right ventriculo/arterial (R-V/A) coupling over PAPm and Pulmonary Hypertension types</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Significant correlations and augmentation over PAPm and Pulmonay Hypertension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of agreement in Right ventriculo/arterial (R-V/A) coupling assessment</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Two independent physicians, both experts in echocardiography, independently re-examined 40 studies, randomly selected from all the acquired echocardiographic images. In order to test the R-V/A coupling interobserver agreement</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Dilated Cardiomyopathy</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>No Pulonary Hypertension</arm_group_label>
    <description>the presence of mean pulmonary pressures (PAPm) at the right heart catheterization &lt; 25 mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postcapillary Pulmonary Hypertension</arm_group_label>
    <description>PAPm ≥ 25 mmHg and postcapillary wedge pressure (PCWP) &gt;15 mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>combined postcapillary/precapillary Pulmonary Hypertension</arm_group_label>
    <description>PAPm ≥ 25 mmHg, PAWP &gt;15 mmHg and diastolic peak gradient (DPG - diastolic pulmonary pressure - PCWP) ≥7 mmHg and/or pulmonary vascular resistence (PVR) &gt;3 WU, where available.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ventriculo-arterial coupling assessment (R-V/A)</intervention_name>
    <description>R-V/A was achieved by computing the R-Elv/P-Ea ratio (Right ventricular elastance/Pulmonary arterial elastance). R-Elv was computed as PAPm / end-systolic area (ESA) of the right ventricle. P-Ea was obtained as (PAPm-PCWP)/ right ventricle stroke volume (R-SV).</description>
    <arm_group_label>No Pulonary Hypertension</arm_group_label>
    <arm_group_label>Postcapillary Pulmonary Hypertension</arm_group_label>
    <arm_group_label>combined postcapillary/precapillary Pulmonary Hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants underwent the exams in the context of heart-transplant or advanced HF
        evaluation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old

          -  Given informed consent

          -  D-CMP

          -  New York Heart Association (NYHA) functional class II or III

          -  Reduced EF (≤ 35%)

        Exclusion Criteria:

          -  Missing the inclusion criteria

          -  Refused informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Bianco, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Cardiology - University &quot;G. d'Annunzio&quot; - Chieti, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University &quot;G. d'Annunzio&quot;</name>
      <address>
        <city>Chieti</city>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niguarda Great Metropolitan Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>March 27, 2019</last_update_submitted>
  <last_update_submitted_qc>March 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ITAB - Institute for Advanced Biomedical Technologies</investigator_affiliation>
    <investigator_full_name>Francesco Bianco</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>heart Failure</keyword>
  <keyword>ventricular elastance</keyword>
  <keyword>dilated cardiomyopathy</keyword>
  <keyword>right heart systolic function</keyword>
  <keyword>right ventriculo-arterial coupling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

